Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01475331 · ClinicalTrials.gov registry record · Phase 2
The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts
A Phase 2 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
NCT01475331 is a Phase 2 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 46 participants.
The verdict
NCT01475331, a Phase 2 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of a chemotherapeutic cocktail with or without prior ethanol lavage for ablation of premalignant pancreatic cysts using endoscopic ultrasound-guided fine needle injection (EUS-FNI) for agent delivery.
Interventions
- DRUG Chemotherapy
- DRUG Ethanol
- DRUG Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2011-11 |
| Est. Completion | 2017-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01475331
The ClinicalTrials.gov registry entry for NCT01475331 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Chemotherapy is the first listed.
NCT01475331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01475331 about?
NCT01475331 is a clinical study titled "The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts". The purpose of this study is to evaluate the efficacy of a chemotherapeutic cocktail with or without prior ethanol lavage for ablation of premalignant pancreatic cysts using endoscopic ultrasound-guided fine needle injection (EUS-FNI) for agent delivery.
What is the current status of trial NCT01475331?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2011-11. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01475331?
The interventions under investigation include: Chemotherapy (DRUG), Ethanol (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT01475331?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.